These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 38943034)

  • 61. Left Atrial Appendage Closure Compared With Oral Anticoagulants for Patients With Atrial Fibrillation: A Systematic Review and Network Meta-Analysis.
    Oliva A; Ioppolo AM; Chiarito M; Cremonesi A; Azzano A; Miccichè E; Mangiameli A; Ariano F; Ferrante G; Reimers B; Garot P; Amabile N; Mehran R; Condorelli G; Stefanini G; Cao D
    J Am Heart Assoc; 2024 Aug; 13(16):e034815. PubMed ID: 39119987
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Risk of major bleeding in patients with non-valvular atrial fibrillation treated with oral anticoagulants: a systematic review of real-world observational studies.
    Deitelzweig S; Farmer C; Luo X; Vo L; Li X; Hamilton M; Horblyuk R; Ashaye A
    Curr Med Res Opin; 2017 Sep; 33(9):1583-1594. PubMed ID: 28644048
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Vitamin K and non-vitamin K antagonist oral anticoagulants for non-valvular atrial fibrillation in real-life.
    Giustozzi M; Vedovati MC; Verdecchia P; Pierpaoli L; Verso M; Conti S; Cianella F; Marchesini E; Filippucci E; Agnelli G; Becattini C
    Eur J Intern Med; 2016 Sep; 33():42-6. PubMed ID: 27394924
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Safety of Direct Oral Anticoagulants and Vitamin K Antagonists in Oldest Old Patients: A Prospective Study.
    Rodríguez-Pascual C; Torres-Torres I; Gómez-Quintanilla A; Ferrero-Martínez AI; Sharma J; Guitián A; Basalo MC; Montero-Magan M; Vilches-Moraga A; Olcoz-Chiva MT; Paredes-Galán E; Rodríguez-Artalejo F
    J Am Med Dir Assoc; 2018 Nov; 19(11):936-941. PubMed ID: 29891182
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Effectiveness and Safety of Non-vitamin K Antagonist Oral Anticoagulants for Atrial Fibrillation and Venous Thromboembolism: A Systematic Review and Meta-analyses.
    Almutairi AR; Zhou L; Gellad WF; Lee JK; Slack MK; Martin JR; Lo-Ciganic WH
    Clin Ther; 2017 Jul; 39(7):1456-1478.e36. PubMed ID: 28668628
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Comparative Real-Life Effectiveness and Safety of Dabigatran or Rivaroxaban vs. Vitamin K Antagonists: A High-Dimensional Propensity Score Matched New Users Cohort Study in the French National Healthcare Data System SNDS.
    Blin P; Dureau-Pournin C; Bénichou J; Cottin Y; Mismetti P; Abouelfath A; Lassalle R; Droz C; Moore N
    Am J Cardiovasc Drugs; 2020 Feb; 20(1):81-103. PubMed ID: 31254174
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Efficacy and safety of direct oral anticoagulants (DOACs) versus vitamin K antagonist (VKA) among patients with atrial fibrillation and hypertrophic cardiomyopathy: a systematic review and meta-analysis.
    Rujirachun P; Charoenngam N; Wattanachayakul P; Winijkul A; Owattanapanich W; Ungprasert P
    Acta Cardiol; 2020 Dec; 75(8):724-731. PubMed ID: 31558097
    [No Abstract]   [Full Text] [Related]  

  • 68. Direct Oral Anticoagulants versus Vitamin K Antagonists in Patients Aged 80 Years and Older.
    Manckoundia P; Nuemi G; Hacquin A; Menu D; Rosay C; Vovelle J; Nuss V; Baudin-Senegas C; Barben J; Putot A
    Int J Environ Res Public Health; 2021 Apr; 18(9):. PubMed ID: 33922331
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Lower Major Bleeding Rates with Direct Oral Anticoagulants in Catheter Ablation of Atrial Fibrillation: an Updated Meta-analysis of Randomized Controlled Studies.
    Brunetti ND; Tricarico L; Tilz RR; Heeger CH; De Gennaro L; Correale M; Ieva R; Di Biase M; Rillig A; Metzner A; Santoro F
    Cardiovasc Drugs Ther; 2020 Apr; 34(2):209-214. PubMed ID: 32080786
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Satisfaction, quality of life and perception of patients regarding burdens and benefits of vitamin K antagonists compared with direct oral anticoagulants in patients with nonvalvular atrial fibrillation.
    Contreras Muruaga MDM; Vivancos J; Reig G; González A; Cardona P; Ramírez-Moreno JM; Martí J; Suárez Fernández C;
    J Comp Eff Res; 2017 Jun; 6(4):303-312. PubMed ID: 28353372
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Efficacy and Safety of Direct Oral Anticoagulants in Kidney Transplantation: A Single-center Pilot Experience.
    Leon J; Sabbah L; Aubert O; Anglicheau D; Delavenne X; Zuber J; Amrouche L; Scemla A; Giura G; Divard G; Legendre C; Sberro-Soussan R
    Transplantation; 2020 Dec; 104(12):2625-2631. PubMed ID: 32044892
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Direct oral anticoagulant- vs vitamin K antagonist-related nontraumatic intracerebral hemorrhage.
    Tsivgoulis G; Lioutas VA; Varelas P; Katsanos AH; Goyal N; Mikulik R; Barlinn K; Krogias C; Sharma VK; Vadikolias K; Dardiotis E; Karapanayiotides T; Pappa A; Zompola C; Triantafyllou S; Kargiotis O; Ioakeimidis M; Giannopoulos S; Kerro A; Tsantes A; Mehta C; Jones M; Schroeder C; Norton C; Bonakis A; Chang J; Alexandrov AW; Mitsias P; Alexandrov AV
    Neurology; 2017 Sep; 89(11):1142-1151. PubMed ID: 28814457
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Safety and efficacy of direct acting oral anticoagulants and vitamin K antagonists in nonvalvular atrial fibrillation - a network meta-analysis of real-world data.
    Hirschl M; Kundi M
    Vasa; 2019 Mar; 48(2):134-147. PubMed ID: 30376416
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Comparison of efficacy and safety between VKAs and DOACs in patients with atrial fibrillation after transcatheter aortic valve replacement: A systematic review and meta-analysis.
    Yan J; Liu M; Zhang Y; Yang D; An F
    Clin Cardiol; 2022 Oct; 45(10):1002-1010. PubMed ID: 36030549
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Effectiveness and safety of oral anticoagulation with non-vitamin K antagonists compared to well-managed vitamin K antagonists in naïve patients with non-valvular atrial fibrillation: Propensity score matched cohort study.
    Denas G; Gennaro N; Ferroni E; Fedeli U; Saugo M; Zoppellaro G; Padayattil Jose S; Costa G; Corti MC; Andretta M; Pengo V
    Int J Cardiol; 2017 Dec; 249():198-203. PubMed ID: 28935464
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Periprocedural anticoagulation during left atrial ablation: interrupted and uninterrupted vitamin K-antagonists or uninterrupted novel anticoagulants.
    Brinkmeier-Theofanopoulou M; Tzamalis P; Wehrkamp-Richter S; Radzewitz A; Merkel M; Schymik G; van Mark G; Bramlage P; Schmitt C; Luik A
    BMC Cardiovasc Disord; 2018 Apr; 18(1):71. PubMed ID: 29703158
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Direct oral anticoagulants versus vitamin K antagonists in patients with atrial fibrillation and bioprosthetic valves: A meta-analysis.
    Yokoyama Y; Briasoulis A; Ueyama H; Mori M; Iwagami M; Misumida N; Takagi H; Kuno T
    J Thorac Cardiovasc Surg; 2023 Jun; 165(6):2052-2059.e4. PubMed ID: 34417050
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Anticoagulation in atrial fibrillation and end-stage kidney disease on hemodialysis: a meta-analysis of randomized trials comparing direct oral anticoagulants with vitamin K antagonists.
    Tscharre M; Steiner D; Mutschlechner D; Ay C; Gremmel T
    Res Pract Thromb Haemost; 2024 Jan; 8(1):102332. PubMed ID: 38404942
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Real-world 2-year outcome of atrial fibrillation treatment with dabigatran, apixaban, and rivaroxaban in patients with and without chronic kidney disease.
    Godino C; Melillo F; Rubino F; Arrigoni L; Cappelletti A; Mazzone P; Mattiello P; Della Bella P; Colombo A; Salerno A; Cera M; Margonato A;
    Intern Emerg Med; 2019 Nov; 14(8):1259-1270. PubMed ID: 31073827
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Real-world Comparisons of Direct Oral Anticoagulants for Stroke Prevention in Asian Patients with Non-valvular Atrial Fibrillation: a Systematic Review and Meta-analysis.
    Chan YH; Lee HF; Chao TF; Wu CT; Chang SH; Yeh YH; See LC; Kuo CT; Chu PH; Wang CL; Lip GYH
    Cardiovasc Drugs Ther; 2019 Dec; 33(6):701-710. PubMed ID: 31745687
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.